Clinical Trial Update: Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the uric acid-lowering activity, safety, and efficacy of adding ulodesine to allopurinol in patients with gout and hyperuricemia has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• Ulodesine (ulodesine)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED